Clover Health Investments Corp. Hits New 52-Week High of $5.34

Clover Health Investments Corp., a small-cap player in the insurance industry, has reached a significant milestone by hitting a new 52-week high of USD 5.34 on June 23, 2026. This achievement marks a notable increase from its 52-week low of USD 1.58, reflecting a substantial upward trend in the stock's performance over the past year. In the context of broader market performance, Clover Health has outpaced the S&P 500, showcasing a year-over-year performance of 22.24%. Despite being a loss-making entity, the company maintains a market capitalization of USD 971 million, indicating its position within the small-cap sector. Clover Health's financial metrics reveal a price-to-book ratio of 3.15, while it currently does not offer a dividend yield. The company's return on equity stands at -27.71%, highlighting the challenges it faces in generating profits. As the stock continues to gain traction, its recent performance underscores the dynamic nature of the insurance market.